← Leaderboards
Beth-Ann Coller
Hawaii Biotech, Inc.
$10,591,331
Attributed
$10,591,331
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2006–10$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$10,591,331 · 3
By mechanism
UC1$6,565,626 · 1
R44$4,025,705 · 2
Top collaborators
No co-investigators on record.
Most similar at Hawaii Biotech, Inc.
Same institution · by research overlap
- David E. Clements$13,267,458
- Michael M Lieberman$4,411,362
- Axel T Lehrer$10,832,675
Others in their field
Top investigators on “Macaca Mulatta”
- Barton F Haynes · Duke University$291,595,855
- Peter Gordon Gillespie · Oregon Health And Science University$83,402,374
- Richard A Gibbs · Baylor College Of Medicine$82,928,769
- Dan H. Barouch · Fred Hutchinson Cancer Center$67,567,747
- David I Watkins · George Washington University$57,087,952
- Rama Rao Amara · Emory University$54,145,017
Research focus
Macaca MulattaRecombinant ProteinsToxicologyDosageVaccine DevelopmentAreaAdverse EffectsDoseComplexBaseBiologicalAntigensCategoriesCause Of DeathDistantClinical AssessmentsCellsAerosolizedClinical EfficacyClinical PathologyBiodefenseAnimal ModelComplementCell Line
Grant awards (4)
Recombinant Subunit Vaccine For Tick-Borne Encephalitis$1,000,000
R44 · FY2010 · AI · contact PI
Recombinant Subunit Vaccine For Tick-Borne Encephalitis$994,040
R44 · FY2009 · AI · contact PI
Recombinant Subunit Vaccine/Prevention of West Nile Vir*$2,031,665
R44 · FY2006 · NS · contact PI
Clinical Development of a Dengue Vaccine$6,565,626
UC1 · FY2004 · AI